A novel mycobacterial Hsp70-containing fusion protein targeting mesothelin augments antitumor immunity and prolongs survival in murine models of ovarian cancer and mesothelioma.
about
Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapiesIncorporation of a hinge domain improves the expansion of chimeric antigen receptor T cells.Immunotherapeutic approaches to ovarian cancer treatment.Antimelanoma CTL recognizes peptides derived from an ORF transcribed from the antisense strand of the 3' untranslated region of TRIT1.Application of antibodies to recombinant heat shock protein 70 in immunohistochemical diagnosis of mycobacterium avium subspecies paratuberculosis in tissues of naturally infected cattleCould mycobacterial Hsp70-containing fusion protein lead the way to an affordable therapeutic cancer vaccine?Effects of Portulaca oleracea L. Polysaccharides on Phenotypic and Functional Maturation of Murine Bone Marrow Derived Dendritic Cells.HSP70 desensitizes osteosarcoma cells to baicalein and protects cells from undergoing apoptosis.HSP70-based anti-cancer immunotherapy.Peripheral T-Cell Reactivity to Heat Shock Protein 70 and Its Cofactor GrpE from Tropheryma whipplei Is Reduced in Patients with Classical Whipple's Disease.Human DKK1 and human HSP70 fusion DNA vaccine induces an effective anti-tumor efficacy in murine multiple myeloma.Cancer Vaccines in Ovarian Cancer: How Can We Improve?A Novel Approach to Anticancer Therapy: Molecular Modules Based on the Barnase:Barstar Pair for Targeted Delivery of HSP70 to Tumor Cells
P2860
Q28395597-34EA3AAA-07F3-4B32-9281-94F6B4D16E26Q34553167-22877F00-E461-4ACF-9BDA-1BF13D39F0C0Q35213535-AB4226B2-8ABF-4DE6-8D7B-1843FF5DC57AQ36664234-3A904ABD-3C8C-4BEE-86BD-ADE5F0D528D0Q37719584-67FF7A5B-0C71-4815-A7DE-46E70CED7B14Q38286381-11077442-B840-4F40-8FF5-C123AD71EB67Q38848551-0A99A5B8-2717-4490-8653-3E5737EE444CQ38993208-FFBBCCED-1F86-428F-B739-C2269556AC4EQ39688737-3A3FDB32-8238-4154-9291-F0BC150F0B75Q40192077-C6848BF5-BFCA-440C-8BC5-9A198D29C4EAQ48507398-D2527B7A-8A46-40F4-A33C-B7617A737DFEQ54385315-359BE2BD-BA73-4E77-997A-2BAC9525C9F1Q58568946-3D708DFF-062A-418F-AAE4-56EC1A4ABE74
P2860
A novel mycobacterial Hsp70-containing fusion protein targeting mesothelin augments antitumor immunity and prolongs survival in murine models of ovarian cancer and mesothelioma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A novel mycobacterial Hsp70-co ...... arian cancer and mesothelioma.
@en
A novel mycobacterial Hsp70-co ...... arian cancer and mesothelioma.
@nl
type
label
A novel mycobacterial Hsp70-co ...... arian cancer and mesothelioma.
@en
A novel mycobacterial Hsp70-co ...... arian cancer and mesothelioma.
@nl
prefLabel
A novel mycobacterial Hsp70-co ...... arian cancer and mesothelioma.
@en
A novel mycobacterial Hsp70-co ...... arian cancer and mesothelioma.
@nl
P2093
P2860
P356
P1476
A novel mycobacterial Hsp70-co ...... varian cancer and mesothelioma
@en
P2093
Ben Forbes
Gilberte Jean-Mary
Glenn Dranoff
Huabiao Chen
Jean Nezivar
Jeffrey Gelfand
Jianping Yuan
Mai Nguyen
Mark C Poznansky
Nadiah Hashim Arrifin
P2860
P2888
P356
10.1186/1756-8722-7-15
P577
2014-02-24T00:00:00Z
P5875
P6179
1028856939